ARCHIVES

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

House Measure Would Eliminate AHRQ, Rescind PCORI, Cut Outcomes Research, And Halt NIH’s Title 42 Hiring Program

July 20, 2012

NCAB, DRCCA Board Asked To Consider Dripping All Staff Investigator Salary Support From Core

October 17, 1980

CCOPs Get $1 Million More, Payline Raised To 228 Plus Exceptions

May 29, 1987

Includes June issue of Business & Regulatory Report.

June 28, 2002

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Mammography Controversy Continues: Task Force Alters Web Site To Clarify Recommendation On Mammography

December 4, 2009